Identification Module
The Identification Module contains basic identifying information about the clinical trial, including the NCT ID, brief title, official title, acronym, organization study ID information, and organization details. This module provides essential identifiers for the trial.
Identification Module path is as follows:
Study -> Protocol Section -> Identification Module
Identification Module
Ignite Creation Date:
2025-12-24 @ 6:51 PM
Ignite Modification Date:
2025-12-24 @ 6:51 PM
NCT ID:
NCT03450057
Brief Title:
Efficacy of Daratumumab in Patients With Relapsed/Refractory Myeloma With Renal Impairment
Official Title:
Efficacy of Daratumumab in Patients With Relapsed/Refractory Myeloma With Renal Impairment
Acronym:
DARE
Study:
NCT03450057
Protocol Section:
NCT03450057